David Hering - 05 Aug 2021 Form 3 Insider Report for Adagio Therapeutics, Inc. (IVVD)

Role
Chief Operating Officer
Signature
/s/ Dorothy Vinsky, Attorney-in-Fact
Issuer symbol
IVVD
Transactions as of
05 Aug 2021
Net transactions value
$0
Form type
3
Filing time
05 Aug 2021, 21:20:05 UTC
Next filing
01 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IVVD Stock Option (Right to Buy) 05 Aug 2021 Common Stock 1,282,310 $12.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One quarter (1/4) of the options shall vest on June 30, 2022, and thereafter, the remainder of the options shall vest in 36 equal monthly installments on the 30th day of each month, subject to the Reporting Person's continuous service on each vesting date.

Remarks:

Exhibit List -- Exhibit 24 -- Power of Attorney